{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:50:38Z","timestamp":1783471838144,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jhep.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,9]],"date-time":"2017-12-09T23:55:57Z","timestamp":1512863757000},"page":"904-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis"],"prefix":"10.1016","volume":"68","author":[{"given":"Jonas","family":"S\u00f6derholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta","family":"Millbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"B\u00fcsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"K\u00f6vamees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schvarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.12.003_b0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.12.003_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jhep.2017.12.003_b0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.12.003_b0020","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2017.12.003_b0025","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1007\/s10620-015-3801-y","article-title":"Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis","volume":"60","author":"Fabrizi","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2017.12.003_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-14-187","article-title":"Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jhep.2017.12.003_b0035","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002431","article-title":"Impact of HCV infection on diabetes patients for the risk of end-stage renal failure","volume":"95","author":"Hwang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2017.12.003_b0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2017.12.003_b0045","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/01.TP.0000131948.29742.24","article-title":"Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation","volume":"78","author":"Bruchfeld","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2017.12.003_b0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jvh.12148","article-title":"Meta-analysis of observational studies: hepatitis C and survival after renal transplant","volume":"21","author":"Fabrizi","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2017.12.003_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2013\/159760","article-title":"Hepatitis C Virus infection and dialysis: 2012 update","volume":"2013","author":"Fabrizi","year":"2013","journal-title":"ISRN Nephrol"},{"key":"10.1016\/j.jhep.2017.12.003_b0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among hemodialysis patients","volume":"38","author":"Goodkin","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jhep.2017.12.003_b0065","unstructured":"Gilead. Product insert for Sovaldi Prescribing information, 2014"},{"key":"10.1016\/j.jhep.2017.12.003_b0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2215\/CJN.07940716","article-title":"Mortality, hospitalization, and quality of life among patients with hepatitis C infection on hemodialysis","volume":"12","author":"Goodkin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2017.12.003_b0075","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1053\/j.gastro.2016.02.078","article-title":"Efficacy of direct-acting antiviral combination for patients with hepatitis C virus genotype 1 infection and severe renal impairment or end-stage renal disease","volume":"150","author":"Pockros","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.12.003_b0080","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4\u20135 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","author":"Roth","year":"2015","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jhep.2017.12.003_b0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1704053","article-title":"Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment","volume":"377","author":"Gane","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2017.12.003_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2893.2001.00300.x","article-title":"Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection\u2013a pilot study","volume":"8","author":"Bruchfeld","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2017.12.003_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/00365521.2016.1228119","article-title":"Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden","volume":"52","author":"B\u00fcsch","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.12.003_b0100","unstructured":"SNR. SNR \u00c5rsrapport 2014_Webb.pdf. 2014."},{"key":"10.1016\/j.jhep.2017.12.003_b0105","doi-asserted-by":"crossref","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jhep.2017.12.003_b0110","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/ki.2008.86","article-title":"Guideline 3: Preventing HCV transmission in hemodialysis units","volume":"73","author":"KDIGO","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2017.12.003_b0115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","article-title":"Hepatitis C: global epidemiology and strategies for control","volume":"22","author":"Lanini","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2017.12.003_b0120","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1681\/ASN.2010060668","article-title":"Effect of kidney transplantation on outcomes among patients with hepatitis C","volume":"22","author":"Roth","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2017.12.003_b0125","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2017.12.003_b0130","article-title":"Chronic hepatitis C increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD","author":"Park","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.12.003_b0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0041-1345(00)00890-3","article-title":"Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients","volume":"32","author":"G\u00fcrsoy","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2017.12.003_b0140","doi-asserted-by":"crossref","first-page":"c133","DOI":"10.1159\/000085442","article-title":"Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course","volume":"100","author":"Mahmoud","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jhep.2017.12.003_b0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-6143.2003.00057.x","article-title":"Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance","volume":"3","author":"Cruzado","year":"2003","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.jhep.2017.12.003_b9005","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/S0168-8278(16)01721-9","article-title":"PS138 \u2013 high mortality in chronic hepatitis C patients in Sweden compared to matched controls \u2013 a nationwide population-based register study from 1997 till 2013","volume":"64","author":"B\u00fcsch","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.12.003_b0150","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jhep.2016.06.011","article-title":"Hepatitis C virus infection and chronic kidney disease: Time for reappraisal","volume":"65","author":"Cacoub","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.12.003_b0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000452730","article-title":"Hepatitis C treatment in chronic kidney disease patients: the kidney disease improving global outcomes perspective","volume":"43","author":"Jadoul","year":"2017","journal-title":"Blood Purif"},{"key":"10.1016\/j.jhep.2017.12.003_b0160","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","article-title":"Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations","volume":"5","author":"Zampino","year":"2013","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2017.12.003_b0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.14218\/JCTH.2015.00051","article-title":"Hepatitis C virus, insulin resistance, and steatosis","volume":"4","author":"Kralj","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhep.2017.12.003_b0170","article-title":"Atherosclerosis as extrahepatic manifestation of chronic infection with hepatitis C virus","volume":"2016","author":"Voulgaris","year":"2016","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.jhep.2017.12.003_b0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/kisup.2011.7","article-title":"Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?","volume":"1","author":"Jager","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jhep.2017.12.003_b0180","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2893.2012.01633.x","article-title":"Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?","volume":"19","author":"Fabrizi","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2017.12.003_b0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/CEJ.0b013e32834572fa","article-title":"Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden","volume":"20","author":"Hofmann","year":"2011","journal-title":"Eur J Cancer Prev"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817324856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817324856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T18:33:04Z","timestamp":1548268384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817324856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0168827817324856"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.12.003","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}